Lumida
/QDEL
⌘K
QuidelOrtho Corp

QuidelOrtho Corp

QDEL
$11.78USD-3.05%-0.37 today

MARKET CAP

807.8M

P/E (TTM)

FWD P/E

DAY RANGE

$12 – $12

52W RANGE

$10
$36

AI Summary

Stalk
TrimMedium

QDEL remains under pressure, trading below its declining 200-day SMA with medium-term distribution evident under the 20-day EMA and capped by the 50-day SMA. Short-term action is neutral around the converged 9/20-day EMA cluster, offering no clear entry signal. Execution is deferred, looking to trim into rallies toward these moving-average resistance levels.

  • 2.8% stock rise post-ADLM showcase highlights diagnostic innovation
  • New York strategic investment underscores institutional confidence
  • Negative earnings yield indicates severe profit pressure
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2023FY 2023FY 2024FY 2025TREND
Sales, Adj.$3.0B$3.0B$2.8B$2.7B
YoY %-8.2%-8.2%-7.2%-1.9%
P / Sales1.7x1.7x1.1x0.7x
EV / Sales2.8x2.8x2.3x2.1x
Gross Profit, Adj.$1.5B$1.5B$1.3B$1.3B
YoY %-22.7%-22.7%-14.1%-1.0%
Margin %49.9%49.9%46.2%46.7%
EV / Gross Profit5.6x5.6x4.9x4.4x
EBITDA, Adj.$714.2M$714.2M$499.2M$496.8M
YoY %-43.6%-43.6%-30.1%-0.5%
Margin %23.8%23.8%17.9%18.2%
EV / EBITDA11.8x11.8x12.6x11.4x
EBIT$139.1M$139.1M$-2.0B$-919.2M
YoY %-85.8%-85.8%-1509.7%+53.1%
Margin %4.6%4.6%-70.5%-33.7%
EV / EBIT60.6x60.6x-3.2x-6.2x
Net Income$-10.1M$-10.1M$-2.1B$-1.1B
YoY %-101.8%-101.8%-20216.8%+44.8%
Net Margin-0.3%-0.3%-73.7%-41.5%
EPS (GAAP)-$0.15-$0.15-$30.54-$16.69
YoY %-101.6%-101.6%-20260.0%+45.4%